Skip to main content
. 2012 Aug 10;7(8):e38117. doi: 10.1371/journal.pone.0038117

Figure 9. 12-h urine output of 15d-PGJ2 during the light and dark phase in PPARγf/f mice treated with DMSO (vehicle), indomethacin (Indo) (5 mg/kg/d), SC-560 (30 mg/kg/d), or NS-398 (5 mg/kg/d) for 3 days.

Figure 9

The compounds were administered from diet and dosing was based on estimated food intake. N = 4–7 in each group. Data are mean ± SE.